Reply to Jack E. Riggs' "Deprenyl, excess mortality, and epidemiological traps". Parkinson's Disease Research Group of the United Kingdom.

Head, J

Reply to Jack E. Riggs' "Deprenyl, excess mortality, and epidemiological traps". Parkinson's Disease Research Group of the United Kingdom. [electronic resource] - Clinical neuropharmacology - 265-6 p. digital

Publication Type: Comment; Letter

0362-5664


Adult
Age Factors
Aged
Aged, 80 and over
Antiparkinson Agents--therapeutic use
Humans
Levodopa--therapeutic use
Middle Aged
Parkinson Disease--drug therapy
Proportional Hazards Models
Randomized Controlled Trials as Topic
Selegiline--therapeutic use
Treatment Outcome